CME Group Inc. (NASDAQ:CME) Shares Sold by Keyes Stange & Wooten Wealth Management LLC

Keyes Stange & Wooten Wealth Management LLC decreased its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,457 shares of the financial services provider’s stock after selling 76 shares during the period. CME Group accounts for 0.5% of Keyes Stange & Wooten Wealth Management LLC’s portfolio, making the stock its 21st largest position. Keyes Stange & Wooten Wealth Management LLC’s holdings in CME Group were worth $917,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in CME. Wayfinding Financial LLC bought a new position in shares of CME Group during the 1st quarter worth $25,000. Cornerstone Planning Group LLC lifted its holdings in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the period. Golden State Wealth Management LLC increased its stake in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after buying an additional 98 shares in the last quarter. Alpine Bank Wealth Management acquired a new position in CME Group in the first quarter valued at approximately $32,000. Finally, Financial Gravity Asset Management Inc. purchased a new stake in shares of CME Group during the first quarter worth $32,000. 87.75% of the stock is owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, Director Daniel G. Kaye sold 500 shares of the company’s stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total transaction of $141,210.00. Following the completion of the transaction, the director directly owned 3,668 shares in the company, valued at approximately $1,035,916.56. This represents a 12.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Phyllis M. Lockett sold 1,060 shares of the stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the transaction, the director directly owned 3,108 shares of the company’s stock, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock worth $3,680,610 over the last 90 days. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CME shares. Bank of America upped their target price on shares of CME Group from $200.00 to $219.00 and gave the company an “underperform” rating in a research note on Wednesday, April 2nd. Royal Bank Of Canada reissued a “sector perform” rating and set a $269.00 price target on shares of CME Group in a report on Thursday, April 3rd. Oppenheimer boosted their price objective on shares of CME Group from $282.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, June 4th. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. decreased their price target on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a research note on Thursday, April 24th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, CME Group presently has an average rating of “Hold” and an average target price of $261.80.

CME Group Stock Performance

CME Group stock opened at $274.70 on Friday. CME Group Inc. has a 12 month low of $193.25 and a 12 month high of $290.79. The stock’s 50-day moving average is $275.89 and its 200-day moving average is $260.65. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $98.99 billion, a price-to-earnings ratio of 27.64, a price-to-earnings-growth ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The firm had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a $1.25 dividend. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. CME Group’s dividend payout ratio is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.